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Summary Direct transplantation of non-Hodgkin's malignant lymphoma into athymic nude mice was
successfully achieved after whole-body irradiation (5 Gy). Twenty-seven per cent (6/22) of transplanted
lymphomas were established as nude mouse lines. The successful lines were derived solely from the patients
with diffuse lymphoma who showed advanced clinical stage, high LDH value, large mass and poor prognosis.
The histological, immunophenotypic and chromosomal characteristics of the nude mouse lines were compared
with those of the original lymphomas, and the proliferative characteristics of the lines were examined. The
transplanted lymphomas substantially retained the characteristics of the original lymphomas, and could be
useful in biological, oncological and therapeutic studies of human malignant lymphoma.
Heterotransplantation of malignant tumours into athymic
nude mice has become quite successful since the first report
in 1969 (Rygaard & Povlsen, 1969), and nude mice tumour
lines have proved to be useful models in many areas of
cancer research because they maintain the original histo-
logical structures and functions for a long time (Giovanella
et al., 1978). However, in the case of haematological
malignancies, transplantation into nuce mide is more difficult
than with solid tumours (Delsol et al., 1980). In order to
improve the transplantability of haematological or lymphoid
tumours, various treatments of nuce mice have been recom-
mended (Gershwin et al., 1978; Watanabe et al., 1978).
We used whole-body gamma-ray irradiation (5 Gy) for
preconditioning of the nude mice at the first implantation
and subsequent passages, and we have succeeded in
establishing six nude mouse lines from non-Hodgkin's
malignant lymphomas of 22 patients. The purpose of this
paper is to describe various characteristics of the established
tumour lines and to discuss the usefulness of them in studies
of human malignant lymphoma.
Materials and methods
Animals and irradiation
Nude mice (BALB/c, nu/nu) are propagated in our institute
and maintained under specific pathogen-free (SPF)
conditions. Male nude mice (6-12 weeks old) were used as
recipients. The mice were given 5 Gy whole body irradiation
from a 137Cs source and kept under SPF conditions
immediately before transplantation.
Clinical materials and methods of implantation
At diagnostic biopsy, fresh specimens of lymph nodes or
tumours were excised aseptically from 21 patients (three
follicular lymphoma, 17 diffuse lymphoma and one mycosis
fungoides). Tumour specimens were cut into small pieces
with scissors in a Petri dish containing Ham's F-10 medium,
antibiotics and 10% calf serum. About 8mm cubes of
tumours thus prepared were implanted subcutaneously with
a trocar. The implants were completed within 4h after
surgical excision. Lymphoma cells in the pleural effusion of
one patient with lymphoblastic lymphoma were collected by
centrifugation. The pellet (containing 2.2 x 108 cells) was also
implanted subcutaneously.
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Tumour take and serial transplantation
When implanted tumours began growing and attained 15-
20mm in diameter, mice were killed by cervical dislocation
and their tumours were excised. Then the tumour pieces were
passaged into at least three new mice. On every passage, this
procedure was repeated for the establishment of the tumour
line. A nude mouse line of more than five passages was
defined as an established one. If tumour take was not
observed within 90 days after implantation, it was regarded
as unsuccessful. Autopsy was performed on all killed mice to
check for metastasis.
Histopathological studies
The specimens of original and nude mouse tumours stained
with Haematoxylin and Eosin were subjected to histo-
pathological analysis according to the Working Formulation
of non-Hodgkin's lymphomas (National Cancer Institute,
1982).
Immunophenotypic studies
Clinical and nude mouse line materials were minced and
pipetted to prepare cell suspensions. Each suspension was
placed on a Ficoll-Hypaque gradient (Nycomed AS, Oslo,
Norway) and centrifuged. The pure lymphoma cells thus
separated were used for the immunophenotypic studies. By
applying the conventional sheep red cell rosetting technique,
cells from clinical specimens were examined for T-cell
markers.
Various monoclonal antibodies including OKIa-1 (Ortho,
Raritan, NJ), LeuHLA-DR (Becton Dickinson, Sunnyvale,
CA), BI (CD20), B2 (CD21), B4 (CD19), J5 (CDIO)
(Coulter, Hialeah, FL) and so on conjugated with fluorescein
isothiocyanate (FITC) were used to characterise the
immunological phenotype in detail by flow cytometry
(Ortho).
Frozen or paraffin-embedded specimens or tumour cell
implants were subjected to immunohistological studies by
using the 'ABC' immunoperoxidase method, as previously
described by Hsu et al. (1981). To detect heavy and light
chains of immunoglobulin on the cell surface and in the
cytoplasm, rabbit antisera (Ortho) were employed. A series
of anti-T cell monoclonal antibodies such as Leu-1 (CD5),
Leu-2a (CD8), Leu-3a (CD4) (Becton Dickinson) and OKT6
(CD1) (Ortho) were also used to study in detail the materials
derived from T cell lymphoma and the nude mouse
counterpart.
Chromosome analysis
The cells from six established nude mouse tumours were
subjected to chromosomal analysis. The details of methods
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were previously described by Minamihisamatsu et al. (1986).
Briefly, approximately 1-2 x 107 cells taken from exponen-
tially growing tumours were incubated at 37°C for 40h in
RPMI-1640 medium containing 20% fetal calf slrum in the
presence of pokeweed mitogen. Colcemid (0.01 ,Ig ml-1) was
added for the last 12h of the culture period. Thereafter, the
cells were subjected to hypotonic treatment in 0.075M KCI,
expanded on the slide and then fixed in methanol/acetic acid
(3:1). The slides were stained for Q-banding with a quina-
crine mustard solution and for G-banding with Giemsa
solution. Thirty metaphase cells were selected per case and
analysed.
Tumour growth and cell cycle parameters
To obtain the growth curve, three perpendicular diameters of
implanted tumours were measured weekly with a sliding
calliper after every passage. Tumour volume (V) was cal-
culated as a hemiellipsoid form according to V=
1/3 x length x width x height and plotted on semi-log graph
paper against time. Volume doubling time (VDT) was
measured from the exponential part of the growth curve.
Single cell suspensions were obtained from a whole tumour
by mincing it and pipetting the paste in the complete
medium. A part of them was stained with 0.4% erythrosine
B to identify dead cells. For the determination of cell cycle
parameters, another cell suspension was centrifuged on a
Ficoll-Hypaque gradient. The separated cells were collected
and adjusted to a cell number of 2 x 105. The cells were
washed twice with chilled 0.1% sodium citrate and directly
stained with chilled 50 yg ml-1 propidium iodide (Sigma, St
Louis, MO) dissolved in a solution of 0.1% sodium citrate
and 0.1% Triton X-100 (Sigma). Subsequently the cells were
incubated with 250 ygml-1 RNase (RNase A, Sigma) at
37°C for 30min and were kept refrigerated for at least 2 h at
4°C. The cells were resuspended by gentle pipetting and
subjected to flow cytometry (Epics C, Coulter). The
percentages of cells in the G1, S and G2+M phases were
calculated by assuming a Gaussian distribution (Krishan,
1975; Vindel0v, 1977; Baisch et al., 1982).
Established tumour fragments in a medium containing
10% dimethylsulphoxide (DMSO) were cryopreserved in
liquid nitrogen.
Results
Tumours or cells of 22 patients with non-Hodgkin's
lymphoma were transplanted into nude mice. Tumour
growth occurred in seven cases. One tumour was lost in first
passage, but six tumours were serially transplanted and
attained more than five passages, so that the six tumour lines
(27%) were successfully established.
Table I shows the characteristics of the patients and their
lymphomas from which the nude tumour lines were
established. Immunological studies on clinical specimens
revealed that four lymphomas showed B cell markers and
one showed T cell markers. The E rosetting technique was
not applied to the remaining one, and immunoperoxidase
studies of a paraffin-embedded specimen failed to find heavy
and light chains.
To clarify further the nature of the six nude mouse lines,
we compared the clinical data on the patients from whom
nude mouse tumour lines were successfully established with
the data on the others (Table II). Implanted three follicular
lymphomas showed no positive tumour take, while six nude
mouse lines were established from 19 diffuse lymphomas.
With regard to B or T cell markers of diffuse lymphoma,
the success rate in establishing tumour lines was 25% (1/4)
for T lymphoma and 31% (5/16) for B lymphoma. Although
T lymphomas were too small in number to be significant, it
seems that nude mouse lines tend to be more easily
established from B lymphoma than from T lymphoma.
On the other hand, it is noteworthy that the six
established tumour lines were preferentially derived from the
patients who were characterised by advanced clinical stage,
high LDH value, large mass and poor response to chemo-
therapy (or short survival).
Table III summarises the cell markers of the six nude
mouse lines. All of the B lymphoma lines showed immuno-
globulins consisting of 2 IgG (A) and 3IgM (k), positive B1
(CD20) and B4 (CD19) as pan-B markers, negative B2
(CD21) indicating limited B cell differentiation, and positive
Ia-antigen OKIa-1 + and/or LeuHLA-DR +. One T
lymphoma line showed positive Leu- 1 (CD5) and Leu-4
(CD3) as pan-T cell markers, Leu-2a (CD8) as a cytotoxic/
suppressor T cell marker, Leu-3a (CD4) as a helper/inducer
T cell marker and OKT6 (CD1) indicating an origin from
cortical thymocytes.
Compared with the clinical specimens from two B
lymphomas showing negative immunoglobulin, the nude
mouse counterparts began to express IgG (A) clearly on the
surface membrane and in the cytoplasm after establishment.
Tumour cells in the nude mouse lines showed normal
diploid or near diploid karyotype. These results were
obtained from 27-28 cells out of 30 examined. As shown in
Table IV, the number of chromosomes was 44, 46, 49, 50
(one case each) and 47 (two cases), indicating human origin
and clonal nature of the established lymphoma cells. The
abnormalities included appearance of marker chromosomes,
missing chromosomes and structural rearrangements, which
were frequently observed in chromosomes 8, 12, 14 and 18.
Among them, the alterations seen in chromosomes 14 (14q+
or 14q-) and 1 (-1) are noteworthy (Figures 1, 2 and 3).
The tumour growth curve of the six nude mouse tumours
was approximated by a logistic function with some lag time.
The lag time and volume doubling time shortened during the
first to third passages. The stable VDT is given in Table V.
The fraction of dead cells ranged from 44 to 14%. The cell
populations participating in tumour growth were analysed by
the flow-cytometric method. The average percentages of cells
in GI, S and G2+M were 56.6+4.0, 31.1 ±3.1 and 12.3 +2.3
respectively. The high percentages of S and G2+M phases
imply a high growth fraction in the nude mouse tumour
lines.
Discussion
Compared with common cancers, leukaemia and lymphoma
are most difficult to transplant into nude mice (Nara &
Miyamoto, 1982). The poor transplantability is supposed to
Table I Human non-Hodgkin's malignant lymphomas which have been transplanted and established
Age Histological subtype
Patients (years) Ann Arbor stage (working formulation) Cell marker of original tumour Implanted tumour
Case 1 male 76 IV B DM n.t. (cIg-*) Axillary lymph node
Case 2 male 75 IV B DL B cell (cIgM, k) Inguinal lymph node
Case 3 female 67 III A DSC B cell (cIgM, k) Cervical lymph node
Case 4 female 12 IV A LBL T cell (CDI+3+4+5+8+) Pleural effusion
Case 5 female 60 IV BE DSC B cell (cIgM, k) Pelvic tumour
Case 6 female 61 IV A DSC B cell (clg-, CD19+20+) Para-aortic tumour
Abbreviations: n.t., not tested; *, examined using paraffin block; DM, diffuse mixed; DL, diffuse large; DSC, diffuse small cleaved;
LBL, lymphoblastic; CD, cluster designation; sm/cIg, surface membrane and cytoplasmic immunoglobulin; k, kappa.358 T. IGARASHI et al.
Table II Relationship between patient's c
failure in establishing a nude m
Pathology (working formulation)
Low grade
FSC (follicular small cleaved)
FM (follicular mixed)
Intermediate grade
DSC (diffuse small cleaved)
DM (diffuse mixed)
DL (diffuse large)
High grade
LBL (lymphoblastic)
MISC (miscellaneous)
Cell origin
B cell (16 cases)
T cell (4 cases)
non-T, non-B (2 cases)
Clinical stage
I+II
III
IV
Total
In diffuse lymphoma (19 casesb)
LDH (on admission)c >400 units
with large mass
initial CRd
Total
aIn one case there was no immunoglobu
cells, but cells of the nude mouse line
bIncluding mycosis fungoides which devel
lymphoma; cNormal LDH value in our
(Cabaud-Wroblewski's unit); dOur stand
chemotherapy with or without local
remission (CR) was judged by the cc
enlarged lymph nodes, palpable mass, or
from peripheral blood and bone marrow,
,linical data and success or be owing to the rich surface antigens of the neoplasms which
ouse tumour line induce a thymus-independent immune reaction. Various
attempts to increase the take rate of lymphoma have been
Successful Unsuccessful made by modifying the methods of heterotransplantation,
e.g. by using an intracranial implant (Epstein et al., 1976),
0 1 premedication with immunosuppressive drugs (Kopper et al.,
0 2 1980; Habu et al., 1981), or anti-lymphocyte serum (Ohsugi
et al., 1980) and whole-body irradiation with or without
3 2 splenectomy (Watanabe et al., 1980; Morgan et al., 1978).
1 1 Athymic and asplenic mice (Lasat mice) and newborn or
1 9 young nude mice were used instead for the same purpose
(Gershwin et al., 1978; Prehn & Outzen, 1977; Hanna &
1 0 Fidler, 1981). The take rate from established haematological
0 1 neoplasms in culture has been increased, but few successes in
direct transplantation have been reported (Nilsson et al.,
5a 11 1977; Sordillo et al., 1983). In contrast, we succeeded in the
1 3 establishment of six lymphoma lines from 22 cases (27%)
0 2 after direct heterotransplantation into nude mice. We used
5Gy whole-body gamma-ray irradiation for preconditioning
0 5 of the nude mice. In the subsequent passages at least three
1 6 mice were used, and the same preconditioning dose was
5 5 given every time. The average percentage serial take was
6 (27%) 16 more than 77% throughout the passages. Among our cases,
no follicular lymphoma gave a positive take, while diffuse
5
3 lymphoma showed a 32% establishment rate. This is much
6 5 higher than that of Watanabe et al. (1980) who succeeded in
1 9 establishing only two lines out of 13 diffuse lymphomas.
6 13b This difference may be partly due to our procedures at
subsequent passages. Lymphomas of high grade malignancy
ilin in the primary tumour have been reported to show higher transplantability than
showed cytoplsmic IgG; those of low grade malignancy (Delsol et al., 1980). Our
loped to cutaneous T cell histopathological results seem to support this. In addition, it
hospital iS under 400 U
therap was clearly observed that the established nude lines were
radiotherapy. Complete preferentially derived from the primaries showing advanced
mplete disappearance Of clinical stage, high LDH value, large mass and poor
leukaemic lymphoma cells prognosis.
and clinical symptoms. All of the B cell nude mouse lymphomas were negative for
Table III Immunophenotypic characteristics of the nude mouse lines
E-rosetting Immunoperoxidase
Case 1 sm/cIgG (i)+, Bl (CD20)+, B2 (CD21)-, B4 (CDl9)±, HLA-DR+, J5 (CDIO)
Case 2 sm/cIgM (k)+, Bl (CD20)+, B2 (CD21)-, B4 (CD19)±, OKIa+, J5 (CD10)-
Case 3 cIgM (k)+, Bi (CD20)+, B2 (CD21)-, B4 (CD19)+, OKIa+, J5 (CDIO)-
Case 4 + OKT6 (CD1)+, Leu4 (CD3)+, Leu3a (CD4)+, Leul (CD5)+, Leu2a (CD8)+
Case 5 sm/cIgM (k)+, Bi (CD20)+, B2 (CD21)-, B4 (CD19)+, HLA-DR+, J5 (CD1O)-
Case 6 - sm/cIgG (i)+, Bi (CD20)+, B2 (CD21)-, B4 (CD19)+, OKIa+, J5 (CDI0)-
Positivity was judged as + for more than 70% cells, + for 40 70% and -for less than 40%. Abbreviations:
CD, cluster designation; sm/clg, surface membrane and cytoplasmic immunoglobulin; k, kappa; A, lambda.
Table IV Cytogenic characteristics of the nude mouse lines
Passage Cell karyotype
Case 1 p-26 49, X, -Y, -4, +7, +12, +13, +marl, +mar2, 2q -, 4q+
Case 2 p-18 50, XY, -1, +lp -, +lq -, +18, +18, +mar, 2q+, 9p -, 12q+
Case 3 p-26 47, XX, -1, +lp-, +lq -, -10, +mar, lp+, 6q -, 7p+, llq -, 12q+, 14q+
Case 4 p-5 46, XX, 6q-, 7p+, 9q+, 14q-
Case 5 p-17 44, X, -X, -8, -13, +mar, 6q-, IOp+, 14q+, iso(18q)
Case 6 p-3 47, XX, -5, -6, -12, +marl, +mar2, +mar3, +mar4, 7p-
Table V Growth characteristics of the nude mouse lines
Volume
doubling % dead Mean % cells in the cell cycle (±s.d.)
time cell
Passage (VDT days) fractionsa GJ phase S phase G2+M phase
Case 1 27 5.8 44.2 57.5+2.6 28.8+ 1.7 13.7+3.2
Case 2 20 8.1 42.6 63.5+ 1.2 25.3+ 1.7 11.2+0.5
Case 3 30 3.4 23.8 57.3+6.7 34.4+7.9 8.3+ 1.3
Case 4 17 3.9 22.6 51.6+6.9 32.8 + 3.2 15.6+4.6
Case 5 23 7.1 25.4 52.9+4.4 33.0+2.4 14.0+4.5
Case 6 4 7.8 14.3 57.0+ 1.5 32.3+2.1 10.7+3.2
Mean 6.0+2.0 29.2 56.6+4.0 31.1 +3.1 12.3+2.3
aThe value of dead cell fraction was judged from % positive erythrosine B staining cells in cell
suspensions which had been prepared from exponentially growing tumours.50 XY, - *3,4S * 4 ;
SIt)'! 4. #'WS'f
13 14 15
Figure 1 Cell karyotype of case 2.
,4%2X9-l.+l..1tlq-40. cAPt ,.6q-U *,?p.llq'
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Figure 2 Cell karyotype of case 3.
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Figure 3 Cell karyotype of case 5.
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B2 marker, but expressed immunoglobulin on the cell surface
and in the cytoplasm, suggesting the terminal stage of B cell
differentiation (Anderson et al., 1984). As mentioned in the
Results section, two of the original lymphomas were not
demonstrated to have immunoglobulin, but the established
nude mouse counterparts expressed IgG (A), indicating the
activation of B cell differentiation including the change in
heavy chain isotype. On the other hand, compared with the
original cells, the T cell nude mouse lymphoma showed no
changes in histology or immunological phenotype as far as
we examined. The presence of the cellular antigens CD1,
CD4, CD5 and CD8 supported the view that this line
retained the fundamental characteristics of common
thymocyte stage (Reinherz & Schlossman, 1980; Weiss et al.,
1986).
As shown in Table IV, the karyotypes of all nude mouse
lines were diploid, which indicated the retention of funda-
mental features of the human chromosome. Some nude
tumour lines showed chromosomal changes such as 14q+
abnormality, which is thought to be specific for the develop-
ment of B-cell lymphoma (Yunis, 1983; Levine et al., 1985),
but it could not be determined whether the other abnor-
malities were specific for B-cell lymphoma or accidental
alterations occurring during the serial passages.
It is often said that established nude mouse lines tend to
maintain the original histology and function compared to 'in
vitro' cell lines because immunological reactivity toward
transplanted tumours is too weak to induce the phenotypic
and genotypic changes (Prehn & Outzen, 1977; Thomson et
al., 1981). This seems to be the case with our nude mouse
tumours.
The growth kinetics studies on the six nude mouse tumour
lines revealed that they were characterised by short VDT
with a high growth fraction. The results seem to reflect the
high malignancy indicated in the clinical data of the patients
with the original lymphoma. In a previous study, we
measured the growth parameters of Burkitt lymphoma
grown in nude mice in detail. The cell cycle time of the
tumour was determined to be 66h (100%), consisting of 31 h
(54%) of tGl, 28h (36%) of tS and 7h (10%) of tG2+M
(Miyamoto & Terashima, 1986). The numbers in parenthesis
represent the fraction of cells at each cell cycle, and are
similar to those of our nude mouse lines, as shown in Table
V. It follows that the other growth parameters may be
similar to those of Burkitt lymphoma. Based on the
similarity, it can be inferred that almost all the lymphomas
were proliferating with a VDT of less than one week.
As indicated in Table II, the original lymphomas were
poorly responsive to chemotherapy, including CHOP and
regional radiation. Experimental chemotherapy of these nude
mouse lymphomas would demonstrate whether the resistance
is caused by the rapid cell proliferation or is intrinsic.
The established lymphoma lines reported here are expected
to be useful in biological and oncological studies of
malignant lymphoma in the future.
The authors wish to thank Miss Masako Minamihisamatsu for her
skillful chromosome analysis, and Mrs Matsumura and Mrs Maeda
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